Wall Street analysts upgraded PTGX, LECO, and JHX. See analyst ratings and price targets for these stocks.
Top Wall Street analysts changed their outlook on these top names.
For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Goldman Sachs analyst Richard Law upgraded Protagonist Therapeutics Inc (NASDAQ:PTGX) from Neutral to Buy and raised the price target from $110 to $186.
Protagonist Therapeutics closed at $145.87 on Friday.
See how other analysts view this stock.
Analysts upgraded Replimune, Madrigal, BBB Foods, Palantir, and Fomento Economico. See other opinions and price targets for these…
Top Wall Street analysts upgraded Grupo Cibest, Lufax, Honeywell, and Gossamer Bio. JBS also received an upgrade. See what…
Wall Street analysts changed ratings on top stocks. Check out the complete list on Benzinga's analyst ratings page. AMAT was…
Top Wall Street analysts changed outlook on top names. Analyst rating changes include upgrades, downgrades, and initiations. See…
Top Wall Street analysts changed outlook on top names. View all changes on analyst ratings page. See what analysts think of these…
Wall Street analysts changed outlook on top names. For full changes, upgrades, downgrades and initiations, see analyst ratings…
